PUMA BIOTECHNOLOGY, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $193.5M | $200.7M | $63.9M |
| Jun 2022 | $173.9M | $193.7M | $52.8M |
| Sep 2022 | $176.6M | $198.8M | $78.0M |
| Dec 2022 | $200.5M | $222.1M | $76.2M |
| Mar 2023 | $170.4M | $196.3M | $61.4M |
| Jun 2023 | $170.1M | $200.5M | $60.0M |
| Sep 2023 | $164.9M | $203.6M | $81.8M |
| Dec 2023 | $177.1M | $230.5M | $84.6M |
| Mar 2024 | $163.2M | $214.1M | $76.8M |
| Jun 2024 | $156.5M | $205.0M | $67.1M |
| Sep 2024 | $149.6M | $220.7M | $67.3M |
| Dec 2024 | $121.2M | $213.3M | $69.2M |
| Mar 2025 | $99.1M | $196.2M | $63.0M |
| Jun 2025 | $90.2M | $194.9M | $54.7M |
| Sep 2025 | $87.6M | $202.9M | $53.5M |
| Dec 2025 | $86.0M | $216.3M | $29.6M |
| Mar 2026 | $64.3M | $192.7M | $36.2M |
| Jun 2026 | $54.2M | $192.7M | $36.5M |